Cubar, Evangeline A.

HRN: 27 44 21  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/26/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/26/2026
02/26/2026
IV
4.5gm
LD
Septicemia
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: